Back
Tourmaline Bio Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
33
TRML
Tourmaline Bio
Last Price:
26.11
Seasonality Move:
28.99%
Buy
62
PLX
Protalix BioTherapeutics
Last Price:
1.31
Seasonality Move:
72.04%
Sell
33
Tourmaline Bio (TRML)
is a Sell
Is Tourmaline Bio a Buy, Sell or Hold?
- The current Tourmaline Bio [TRML] share price is $28.40. The Score for TRML is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- TRML is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.20. The Score for PLX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TRML Stock Price Chart
What is Tourmaline Bio's stock price today?
-
The Tourmaline Bio share price today is $28.40
The current trend is moderately bearish and TRML is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
TRML Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 61.14 | Buy |
| Chaikin Money Flow: | -57777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.23 - 28.37) | Buy |
| Bollinger Bands (100): | (14.02 - 25.32) | Buy |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 57.75 | Buy |
| Chaikin Money Flow: | 72654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.21) | Buy |
| Bollinger Bands (100): | (0.99 - 1.17) | Buy |
TRML Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.23 | Buy |
| 20-day SMA: | 27.43 | Buy |
| 50-day SMA: | 24.44 | Buy |
| 200-day SMA: | 22.41 | Buy |
| 8-day EMA: | 27.67 | Buy |
| 20-day EMA: | 27.07 | Buy |
| 50-day EMA: | 24.65 | Buy |
| 200-day EMA: | 22.12 | Buy |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Sell |
| 20-day SMA: | 1.14 | Buy |
| 50-day SMA: | 1.09 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 1.11 | Buy |
| 200-day EMA: | 1.2 | Sell |
Tourmaline Bio Earnings Growth & TRML Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.52 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tourmaline Bio Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||